Table 1.
Relationship Between TF-PDC and Clinicopathological Features of AML Patients
| Prognostic Variables | No. | TF-PDC | |||
|---|---|---|---|---|---|
| Negative | Positive | P-value | |||
| Gender | |||||
| Female | 66 | 38 | 28 | X2= 0.906 | 0.341 |
| Male | 97 | 63 | 34 | ||
| Age | |||||
| >46 | 85 | 54 | 31 | X2= 0.185 | 0.667 |
| ≤46 | 78 | 47 | 31 | ||
| FAB classification | |||||
| M4 | 80 | 53 | 27 | X2= 1.225 | 0.268 |
| M5 | 83 | 48 | 35 | ||
| ELN risk classification | |||||
| Favorable | 63 | 35 | 28 | X2= 7.228 | 0.027 |
| Intermediate | 49 | 38 | 11 | ||
| Poor | 51 | 28 | 23 | ||
| Cytogenetics abnormality | |||||
| Favorable | 42 | 26 | 16 | X2= 1.294 | 0.523 |
| Intermediate | 71 | 47 | 24 | ||
| Poor | 50 | 28 | 22 | ||
| Gene mutation | |||||
| NPM1 | 19 | 13 | 6 | X2=0.381 | 0.537 |
| Flt3-ITD | 24 | 9 | 15 | X2=7.416 | 0.008 |
| No. of chemotherapy before CR | 1.93 (1–3) | 2.9 (1–4) | t=5.19 | 0.00 | |
| Median WBC (x109, range) | 55.6 (0.87–307) | 51.1 (1.8–474) | t=5.18 | 0.00 | |
| Median Hb concentration (g/dL, range) | 80.8 (47–151) | 81.8 (38–135) | t=6.88 | 0.00 | |
| Median platelet count (x109, range) | 79.2 (9–381) | 76.4 (8–258) | t=3.61 | 0.00 | |
| Bone marrow blast (%, range) | 59.7 (21–98.7) | 68.4 (20–94) | t=32.03 | 0.00 | |